Menu
Recruiting NCT06481111

Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital

Observational Hypovitaminosis D

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: supplementary treatment with vitamin D.
Who it may be relevant to
Registry conditions: Hypovitaminosis D. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The Endocrinology Unit of the IRCCS San Raffaele Hospital is dedicated to establishing a prospective single-center registry with data from patients undergoing vitamin D supplementation, initiating their first visit to the outpatient unit until December 2029. 1000 patients will be enrolled, aligning with the unit's recent patient influx for hypovitaminosis D. The registry's goal is to assess the epidemiological trend, identify risk factors, and evaluate the diagnostic and therapeutic clinical management strategies for hypovitaminosis D. It will involve collecting clinical, laboratory, and historical data during outpatient visits, adhering to the standard diagnostic and therapeutic protocols for endocrine-metabolic diseases. This data collection is expected to continue for a duration of ten years.

Interventions

  • Drug supplementary treatment with vitamin D
    observational design

Primary outcome measures

  • Change from baseline of data in outpatient accessing Endocrinology Unit of the IRCCS San Raffaele Hospital for endocrine-metabolic diseases who are on supplementary treatment with vitamin D. [Time frame: 10 years]

Eligibility criteria

Inclusion criteria

  • Adult men and women (age ≥ 18 years) regardless of fertility status and pregnancy/breastfeeding conditions
  • Vitamin D supplementation, with any formulation and dosage
  • Signing of informed consent

Exclusion criteria

  • Patients unable to understand and sign informed consent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-only

Study locations

Italy · 1 center
  • IRCCS Ospedale San Raffaele — Milan

Identifiers

NCT: NCT06481111 · "REGIDO"

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗